Search

Displaying results 3751 - 3760 of 6076 in total
  1. Drug

    SLV319

    go.drugbank.com/drugs/DB05077
    Experimental

    It is developed for the treatment of obesity and other metabolic disorders.

  2. Drug

    Metralindole

    go.drugbank.com/drugs/DB09306
    Experimental

    In Russia, this drug was investigated for potential antidepressant activity.

  3. Drug

    R1295

    go.drugbank.com/drugs/DB05122
    Experimental

    R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis.

  4. Drug

    Fasedienol

    go.drugbank.com/drugs/DB04968
    Investigational

    PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder).

  5. Drug

    Shark liver oil

    go.drugbank.com/drugs/DB11088
    Approved

    Shark oil is extracted from the livers of sharks, which can account for up to 25% of their total body weight.

  6. Drug

    Borage oil

    go.drugbank.com/drugs/DB11238
    Approved

    GLA, which accounts for approximately 24% of the oil, is converted to dihomo-γ-linolenic acid (DGLA) which acts as a precursor to anti-inflammatory mediators such as 1-series prostaglandins and the 3-series

  7. Drug

    Clometocillin

    go.drugbank.com/drugs/DB13686
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  8. Drug

    Captodiame

    go.drugbank.com/drugs/DB09014
    Experimental

    Captodiame has been suggested for use in preventing benzodiazepine withdrawal syndrome.

  9. Drug

    PRX-07034

    go.drugbank.com/drugs/DB05993
    Experimental

  10. Drug

    KOS-2187

    go.drugbank.com/drugs/DB05946
    Experimental

    KOS-2187, a novel erythromycin-based motilin agonist, or motilide, as a clinical candidate for the treatment of gastrointestinal motility disorders such as gastroparesis and gastroesophageal reflux disease